PMC:7068163 / 4990-5325 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"78","span":{"begin":77,"end":80},"obj":"Gene"},{"id":"79","span":{"begin":18,"end":26},"obj":"Species"},{"id":"80","span":{"begin":190,"end":197},"obj":"Species"}],"attributes":[{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"Gene:4335"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Tax:694009"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We found that the SARS-CoV E gene screening assay with the QuantiTect Virus +Rox Vial kit showed moderate to high amounts of unspecific signals in late cycles in 61% (451/743) of the tested patient samples and also of negative extraction and non-template controls (Table, Figure 2), which complicated the evaluation of the qPCR result."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":29,"end":33},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma74402"}],"text":"We found that the SARS-CoV E gene screening assay with the QuantiTect Virus +Rox Vial kit showed moderate to high amounts of unspecific signals in late cycles in 61% (451/743) of the tested patient samples and also of negative extraction and non-template controls (Table, Figure 2), which complicated the evaluation of the qPCR result."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":18,"end":26},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"We found that the SARS-CoV E gene screening assay with the QuantiTect Virus +Rox Vial kit showed moderate to high amounts of unspecific signals in late cycles in 61% (451/743) of the tested patient samples and also of negative extraction and non-template controls (Table, Figure 2), which complicated the evaluation of the qPCR result."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":29,"end":33},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T41","span":{"begin":70,"end":75},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T42","span":{"begin":136,"end":143},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T43","span":{"begin":183,"end":189},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"We found that the SARS-CoV E gene screening assay with the QuantiTect Virus +Rox Vial kit showed moderate to high amounts of unspecific signals in late cycles in 61% (451/743) of the tested patient samples and also of negative extraction and non-template controls (Table, Figure 2), which complicated the evaluation of the qPCR result."}

{"project":"LitCovid-sentences","denotations":[{"id":"T39","span":{"begin":0,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We found that the SARS-CoV E gene screening assay with the QuantiTect Virus +Rox Vial kit showed moderate to high amounts of unspecific signals in late cycles in 61% (451/743) of the tested patient samples and also of negative extraction and non-template controls (Table, Figure 2), which complicated the evaluation of the qPCR result."}